161 related articles for article (PubMed ID: 16376499)
1. Characterization of kynurenine aminotransferase III, a novel member of a phylogenetically conserved KAT family.
Yu P; Li Z; Zhang L; Tagle DA; Cai T
Gene; 2006 Jan; 365():111-8. PubMed ID: 16376499
[TBL] [Abstract][Full Text] [Related]
2. Genomic organization and expression analysis of mouse kynurenine aminotransferase II, a possible factor in the pathophysiology of Huntington's disease.
Yu P; Mosbrook DM; Tagle DA
Mamm Genome; 1999 Sep; 10(9):845-52. PubMed ID: 10441733
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient mice.
Yu P; Di Prospero NA; Sapko MT; Cai T; Chen A; Melendez-Ferro M; Du F; Whetsell WO; Guidetti P; Schwarcz R; Tagle DA
Mol Cell Biol; 2004 Aug; 24(16):6919-30. PubMed ID: 15282294
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain.
Guidetti P; Amori L; Sapko MT; Okuno E; Schwarcz R
J Neurochem; 2007 Jul; 102(1):103-11. PubMed ID: 17442055
[TBL] [Abstract][Full Text] [Related]
5. Sequence variants in kynurenine aminotransferase II (KAT II) orthologs determine different potencies of the inhibitor S-ESBA.
Pellicciari R; Venturoni F; Bellocchi D; Carotti A; Marinozzi M; Macchiarulo A; Amori L; Schwarcz R
ChemMedChem; 2008 Aug; 3(8):1199-202. PubMed ID: 18537204
[No Abstract] [Full Text] [Related]
6. Kynurenine aminotransferase 3/glutamine transaminase L/cysteine conjugate beta-lyase 2 is a major glutamine transaminase in the mouse kidney.
Yang C; Zhang L; Han Q; Liao C; Lan J; Ding H; Zhou H; Diao X; Li J
Biochem Biophys Rep; 2016 Dec; 8():234-241. PubMed ID: 28955961
[TBL] [Abstract][Full Text] [Related]
7. Cloning and functional expression of a soluble form of kynurenine/alpha-aminoadipate aminotransferase from rat kidney.
Buchli R; Alberati-Giani D; Malherbe P; Köhler C; Broger C; Cesura AM
J Biol Chem; 1995 Dec; 270(49):29330-5. PubMed ID: 7493966
[TBL] [Abstract][Full Text] [Related]
8. Selective and competitive inhibition of kynurenine aminotransferase 2 by glycyrrhizic acid and its analogues.
Yoshida Y; Fujigaki H; Kato K; Yamazaki K; Fujigaki S; Kunisawa K; Yamamoto Y; Mouri A; Oda A; Nabeshima T; Saito K
Sci Rep; 2019 Jul; 9(1):10243. PubMed ID: 31308447
[TBL] [Abstract][Full Text] [Related]
9. Isolation, characterization, and functional expression of kynurenine aminotransferase cDNA from the yellow fever mosquito, Aedes aegypti(1).
Fang J; Han Q; Li J
Insect Biochem Mol Biol; 2002 Aug; 32(8):943-50. PubMed ID: 12110301
[TBL] [Abstract][Full Text] [Related]
10. Expression, purification and crystallization of human kynurenine aminotransferase 2 exploiting a highly optimized codon set.
Sun G; Nematollahi A; Nadvi NA; Kwan AH; Jeffries CM; Church WB
Protein Expr Purif; 2016 May; 121():41-5. PubMed ID: 26773745
[TBL] [Abstract][Full Text] [Related]
11. Prolonged therapy with antidepressants increases hippocampal level of kynurenic acid and expression of Kat1 and Kat2 genes.
Kocki T; Urbańska EM; Kocki J; Kloc R; Kocka K; Olajossy M; Owe-Larsson B
Pharmacol Rep; 2018 Aug; 70(4):737-745. PubMed ID: 29960193
[TBL] [Abstract][Full Text] [Related]
12. Homology modeling of human kynurenine aminotransferase III and observations on inhibitor binding using molecular docking.
Nematollahi A; Church WB; Nadvi NA; Gorrell MD; Sun G
Cent Nerv Syst Agents Med Chem; 2014; 14(1):2-9. PubMed ID: 24739074
[TBL] [Abstract][Full Text] [Related]
13. Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry.
Guidetti P; Hoffman GE; Melendez-Ferro M; Albuquerque EX; Schwarcz R
Glia; 2007 Jan; 55(1):78-92. PubMed ID: 17024659
[TBL] [Abstract][Full Text] [Related]
14. Kynurenic acid and kynurenine aminotransferase in heart.
Baran H; Amann G; Lubec B; Lubec G
Pediatr Res; 1997 Mar; 41(3):404-10. PubMed ID: 9078543
[TBL] [Abstract][Full Text] [Related]
15. Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease.
Sapko MT; Guidetti P; Yu P; Tagle DA; Pellicciari R; Schwarcz R
Exp Neurol; 2006 Jan; 197(1):31-40. PubMed ID: 16099455
[TBL] [Abstract][Full Text] [Related]
16. Structure of the PLP-Form of the Human Kynurenine Aminotransferase II in a Novel Spacegroup at 1.83 Å Resolution.
Nematollahi A; Sun G; Harrop SJ; Hanrahan JR; Church WB
Int J Mol Sci; 2016 Mar; 17(4):446. PubMed ID: 27023527
[TBL] [Abstract][Full Text] [Related]
17. Cerebrolysin lowers kynurenic acid formation--an in vitro study.
Baran H; Kepplinger B
Eur Neuropsychopharmacol; 2009 Mar; 19(3):161-8. PubMed ID: 19008081
[TBL] [Abstract][Full Text] [Related]
18. Structure, expression, and function of kynurenine aminotransferases in human and rodent brains.
Han Q; Cai T; Tagle DA; Li J
Cell Mol Life Sci; 2010 Feb; 67(3):353-68. PubMed ID: 19826765
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of a soluble kynurenine aminotransferase from rat brain: identity with kidney cysteine conjugate beta-lyase.
Alberati-Giani D; Malherbe P; Köhler C; Lang G; Kiefer V; Lahm HW; Cesura AM
J Neurochem; 1995 Apr; 64(4):1448-55. PubMed ID: 7891071
[TBL] [Abstract][Full Text] [Related]
20. Kynurenic acid metabolism in the brain of HIV-1 infected patients.
Baran H; Hainfellner JA; Kepplinger B; Mazal PR; Schmid H; Budka H
J Neural Transm (Vienna); 2000; 107(10):1127-38. PubMed ID: 11129102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
